On June 26, Everest Group hosted a webinar titled, “What’s Driving the Surge in Life Sciences IT Outsourcing?”
Though the life sciences industry has faced challenges such as the patent cliff, low drug approval rates, and low R&D productivity, there is growing confidence in the industry to “manage” these challenges. The role of data has become highly critical, but the volume, variety, and velocity of data is fundamentally impacting how life sciences organizations view their IT service needs.
Interestingly, both analytics and infrastructure services require the life sciences industry to look at their sourcing portfolio and think of two primary imperatives – one, creating a strategic roadmap for the adoption of these services, and two, selecting the right service partner who can take them the whole distance.
This one-hour webinar answered the following questions:
This is the deck used during the presentation.